Evogene Ltd. (EVGN) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Evogen third quarter 2025 results conference call. All participants are at present in listen-only mode. Following management's formal presentation, we will open the question and answer session. You may send questions via chat. Please type your name and company before your question. As a reminder, this conference is being recorded November 20, 2025. Before we begin, I would like to caution that certain statements made during this Earnings Conference call by Evogen's management will constitute forward-looking statements that relate to future events. This presentation contains forward-looking statements relating to future events, and Avagen Ltd., the company, may from time to time make other statements regarding our outlook or expectation for future financial or operating results and or other matters regarding or affecting us that are considered forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995, the PSLRA, and other securities laws as demand. Statements that are not statements or historical facts may be deemed to be forward-looking statements. Such forward-looking statements may be identified by the use of such words as believe, expect, anticipate, should, planned, estimate, intent and potential, or words of similar meaning. We are using forward-looking statements in this presentation when we discussed our value drivers, commercialization efforts and timing, product development and launches, estimate market sizes and milestones, pipeline, as well as our capabilities and technology. Such statements are based on current expectations, estimates, projections and assumptions, describe opinions about future events, involve certain risks and uncertainties, which are difficult to predict and are not guaranteed of futur...